Description
Specifications
| Form | Lyophilized powder, single vial |
| Contents | GHK-Cu 50 mg · BPC-157 10 mg · TB-500 10 mg · KPV 10 mg |
| Made in | USA |
| Testing | Third-party identity and purity, every lot |
| GHK-Cu | C₁₄H₂₂CuN₆O₄ · MW 401.9 · CAS 89030-95-5 |
| BPC-157 | C₆₂H₉₈N₁₆O₂₂ · MW 1419.5 · CAS 137525-51-0 |
| TB-500 | C₂₁₂H₃₅₀N₅₆O₇₈S · MW 4963.4 · CAS 77591-33-4 |
| KPV | C₁₆H₃₀N₄O₄ · MW 342.4 · CAS 67727-97-3 |
How Is This Blend Studied?
KLOW combines four peptides researched for complementary roles in tissue repair and inflammatory signaling. GHK-Cu is studied for collagen synthesis and matrix remodeling, BPC-157 for cytoprotective and angiogenic signaling, TB-500 (thymosin beta-4) for actin binding and cell migration, and KPV (the C-terminal fragment of alpha-MSH) for NF-κB pathway activity. The blend is used in preclinical models of wound healing and tissue repair.
Storage
Store the sealed vial at −20 °C for long-term storage, or 2–8 °C short-term, away from light. Once reconstituted in the lab, keep at 2–8 °C and avoid repeated freeze-thaw cycles.
FAQ
How is KLOW different from GLOW?
GLOW contains GHK-Cu, BPC-157 and TB-500. KLOW adds 10 mg of KPV.
Is a Certificate of Analysis available?
Yes. Tap “View Certificate of Analysis” on this page for the current lot’s third-party COA.
Do you provide use or dosing guidance?
No. This product is sold strictly for laboratory research, and orders indicating human or animal use are cancelled.
For laboratory research use only. Not for human consumption.
